The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022
September 8th 2022Novel insights into the risk-benefit profile of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD) were provided by late-breaking data presented at ERS 2022 regarding the InPedILD clinical trial.